Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Fitzgerald, K.
and
Healy, D.
1995.
Dystonias and dyskinesias of the jaw associated with the use of SSRIs.
Human Psychopharmacology: Clinical and Experimental,
Vol. 10,
Issue. 3,
p.
215.
Al-Adwani, A.
1995.
Brain damage and tardive dyskinesia.
British Journal of Psychiatry,
Vol. 167,
Issue. 3,
p.
410.
Devane, C. Lindsay
1995.
Comparative safety and tolerability of selective serotonin reuptake inhibitors.
Human Psychopharmacology: Clinical and Experimental,
Vol. 10,
Issue. S3,
p.
S185.
1995.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 29,
Issue. 4,
p.
690.
McGrath, Patrick J.
Quitkin, Frederic M.
and
Klein, Donald F.
1995.
Bromocriptine Treatment of Relapses Seen During Selective Serotonin Re-uptake Inhibitor Treatment of Depression.
Journal of Clinical Psychopharmacology,
Vol. 15,
Issue. 4,
p.
289.
1995.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 29,
Issue. 3,
p.
516.
Vandel, P.
Bonin, B.
Vandel, S.
Sechter, D.
and
Bizouard, P.
1996.
CYP 2D6 PM phenotype hypothesis of antidepressant extrapyramidal side-effects.
Medical Hypotheses,
Vol. 47,
Issue. 6,
p.
439.
Jellinger, Kurt A.
1996.
Handbuch der Gerontopsychiatrie.
p.
202.
Basson, Rosemary
1996.
Sexuality and parkinson's disease.
Parkinsonism & Related Disorders,
Vol. 2,
Issue. 4,
p.
177.
Thomas, P
Roche, J
Maron, M
Cotencin, O
Vaiva, G
and
Goudemand, M
1996.
Severe extrapyramidal symptoms with fluvoxamine despite neuroleptics withdrawal.
European Psychiatry,
Vol. 11,
Issue. 5,
p.
273.
Tiihonen, J.
Kuoppamäki, M.
Syvälahti, E.
Någren, K.
Eronen, E.
Hietala, J.
and
Bergman, J.
1996.
Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.
Psychopharmacology,
Vol. 126,
Issue. 4,
p.
277.
Salokangas, R. K. R.
Saarijärvi, S.
Taiminen, T.
Kallioniemi, H.
Lehto, H.
Niemi, H.
Tuominen, J.
Ahola, V.
and
Syvälahti, E.
1996.
Citalopram as an adjuvant in chronic schizophrenia: a double‐blind placebo‐controlled study.
Acta Psychiatrica Scandinavica,
Vol. 94,
Issue. 3,
p.
175.
Armitage, Roseanne
1996.
Effects of Antidepressant Treatment on Sleep EEG in Depression.
Journal of Psychopharmacology,
Vol. 10,
Issue. 1_suppl,
p.
22.
Farragher, Barbara
and
Walsh, Noel
1997.
Delayed onset of extrapyramidal side-effects on combining paroxetine with risperidone.
Irish Journal of Psychological Medicine,
Vol. 14,
Issue. 3,
p.
117.
Suzuki, Toshihito
Kurita, Hirofumi
Hori, Takafumi
Sasaki, Megumi
Baba, Atsuomi
Shiraishi, Hiroyasu
and
Piletz, John E.
1997.
The pisa syndrome (pleurothotonus) during antidepressant therapy.
Biological Psychiatry,
Vol. 41,
Issue. 2,
p.
234.
GORMLEY, NIALL
WATTERS, LIAM
and
LAWLOR, BRIAN A.
1997.
Extrapyramidal Side-Effects in Elderly Patients Exposed to Selective Serotonin Reuptake Inhibitors.
Human Psychopharmacology: Clinical and Experimental,
Vol. 12,
Issue. 2,
p.
139.
Schreiber, Shaul
and
Pick, Chaim G.
1997.
Paroxetine for Secondary Stuttering: Further Interaction of Serotonin and Dopamine.
The Journal of Nervous & Mental Disease,
Vol. 185,
Issue. 7,
p.
465.
Stokes, Peter E.
and
Holtz, Aliza
1997.
Fluoxetine tenth anniversary update: the progress continues.
Clinical Therapeutics,
Vol. 19,
Issue. 5,
p.
1135.
1997.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 31,
Issue. 5,
p.
772.
Poyurovsky, Michael
Schneidman, Michael
and
Weizman, Abraham
1997.
Successful treatment of fluoxetine‐indueed dystonia with low‐dose mianserin.
Movement Disorders,
Vol. 12,
Issue. 6,
p.
1102.
eLetters
No eLetters have been published for this article.